Published in Transplantation on June 15, 2007
Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice. Diabetes (2012) 2.17
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med (2010) 2.01
Regulatory immune cells in transplantation. Nat Rev Immunol (2012) 1.82
Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. Proc Natl Acad Sci U S A (2011) 0.97
Translating tolerogenic therapies to the clinic - where do we stand? Front Immunol (2012) 0.91
CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis. Am J Pathol (2010) 0.86
CD4+ regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant (2010) 0.84
Regulatory T cells in transplantation. Transplant Proc (2011) 0.81
Lung function early after lung transplantation is correlated with the frequency of regulatory T cells. Surg Today (2011) 0.76
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol (2002) 3.41
A simple method to cure established tumors by inflammatory killing of normal cells. Nat Biotechnol (2004) 2.39
Mechanisms of rejection: current perspectives. Transplantation (2012) 2.19
Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell (2010) 2.10
IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med (2005) 2.07
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med (2010) 2.01
Regulatory immune cells in transplantation. Nat Rev Immunol (2012) 1.82
Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci U S A (2007) 1.81
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes (2009) 1.78
IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol (2011) 1.72
Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J Am Soc Nephrol (2010) 1.72
Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J Immunol (2004) 1.59
Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol (2002) 1.59
Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation (2010) 1.55
Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg (2012) 1.45
Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant (2004) 1.40
Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells. Eur J Immunol (2008) 1.36
The impact of memory T cells on rejection and the induction of tolerance. Transplantation (2006) 1.34
Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33
Impact of hepatic rearterialization on reperfusion injury and outcome after mouse liver transplantation. Transplantation (2003) 1.31
Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol (2006) 1.28
Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol (2011) 1.25
Moving to tolerance: clinical application of T regulatory cells. Semin Immunol (2011) 1.25
Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation (2008) 1.22
Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. Int J Biochem Cell Biol (2008) 1.18
Regenerative medicine and organ transplantation: past, present, and future. Transplantation (2011) 1.14
Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. Transplantation (2006) 1.14
Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells. J Immunol (2008) 1.09
Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol (2010) 1.08
The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant (2010) 1.07
Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells (2008) 1.07
Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol (2006) 1.07
Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv Drug Deliv Rev (2005) 1.03
Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? Transplantation (2007) 1.03
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A (2013) 1.03
Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation (2009) 1.02
Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance? Transplantation (2011) 1.00
Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine. Front Biosci (2007) 1.00
Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection. Sci Transl Med (2011) 0.99
In vivo quantification of VCAM-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging. PLoS One (2010) 0.99
Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+Foxp3+ T cells. Transplantation (2010) 0.96
Costimulation blockade: current perspectives and implications for therapy. Transplantation (2013) 0.95
Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques. J Immunol Methods (2005) 0.95
Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection. Eur J Immunol (2008) 0.95
Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation (2003) 0.95
Transplantation tolerance: lessons from experimental rodent models. Transpl Int (2007) 0.94
A comparison of protocols used to generate insulin-producing cell clusters from mouse embryonic stem cells. Stem Cells (2008) 0.94
Immunogenicity of embryonic stem cell-derived progenitors after transplantation. Curr Opin Organ Transplant (2011) 0.94
Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci (2014) 0.93
Regulatory T cells as modulators of chronic allograft dysfunction. Curr Opin Immunol (2011) 0.93
Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation (2011) 0.93
Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92
Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells. Eur J Immunol (2011) 0.92
Induction of transplantation tolerance-the potential of regulatory T cells. Transpl Immunol (2005) 0.92
Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model. Transplantation (2013) 0.92
Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters. Transplantation (2009) 0.91
Translating tolerogenic therapies to the clinic - where do we stand? Front Immunol (2012) 0.91
Regulatory cells in transplantation. Novartis Found Symp (2003) 0.90
Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen. J Immunol (2004) 0.90
Mesenchymal stromal cells in transplantation rejection and tolerance. Cold Spring Harb Perspect Med (2013) 0.90
Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy. Transplantation (2011) 0.90
T regulatory cells and the control of alloimmunity: from characterisation to clinical application. Curr Opin Immunol (2010) 0.90
Donor reactive regulatory T cells. Curr Opin Organ Transplant (2009) 0.90
Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol (2010) 0.89
Tolerance: one transplant for life. Transplantation (2014) 0.89
Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation. Transplantation (2010) 0.89
Regulatory T cells in transplantation. Curr Opin Immunol (2002) 0.89
Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters. PLoS One (2010) 0.89
CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection. Transplantation (2006) 0.89
Examination of serum miRNA levels in kidney transplant recipients with acute rejection. Transplantation (2014) 0.88
Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells. Mech Ageing Dev (2010) 0.88
Induction of transplantation tolerance through regulatory cells: from mice to men. Immunol Rev (2014) 0.88
An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Transpl Int (2007) 0.87
Understanding FOXP3: progress towards achieving transplantation tolerance. Transplantation (2007) 0.87
How regenerative medicine may contribute to the achievement of an immunosuppression-free state. Transplantation (2011) 0.87
Dependency of the trans vivo delayed type hypersensitivity response on the action of regulatory T cells: implications for monitoring transplant tolerance. Transplantation (2007) 0.86
Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice. PLoS One (2010) 0.86
Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells. Immunol Rev (2011) 0.86
CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis. Am J Pathol (2010) 0.86
Platelet-endothelial cell adhesion molecule-1 (CD31) expression on donor endothelial cells attenuates the development of transplant arteriosclerosis. Transplantation (2002) 0.85
Regulatory T cells: hypes and limitations. Curr Opin Organ Transplant (2008) 0.85
Mesoangioblasts suppress T cell proliferation through IDO and PGE-2-dependent pathways. Stem Cells Dev (2012) 0.85
The where and when of T cell regulation in transplantation. Trends Immunol (2012) 0.85